Ureteric cancer – Life with Disease

Go back

Ureteric cancer, also known as urothelial carcinoma of the ureter, is a rare but serious condition where abnormal cells develop in the tubes that carry urine from the kidneys to the bladder. Though uncommon, this disease requires careful attention and comprehensive treatment to offer the best possible chance of recovery.

Prognosis and What to Expect

Understanding what lies ahead after a diagnosis of ureteric cancer can help you and your loved ones prepare emotionally and practically for the journey. The outlook for this condition depends heavily on how early the cancer is detected and how deeply it has invaded the ureter wall or spread beyond it.[1]

For cancers caught early, when they remain on the surface of the ureter lining, the prognosis is generally encouraging. More than 90% of patients with superficial cancers confined to the renal pelvis or ureter can be cured with appropriate treatment.[19] These are the cases where the disease has not yet penetrated deeply into the tissue.

However, when the cancer has grown deeper into the ureter wall, the outlook becomes more challenging. Patients with deeply invasive tumors that are still confined to the renal pelvis or ureter have approximately a 10% to 15% likelihood of cure.[19] This statistic reflects the aggressive nature of advanced ureteric cancer and the difficulty in completely eradicating it once it has spread into surrounding tissues.

When cancer has penetrated through the entire wall of the ureter or has spread to distant parts of the body, known as metastatic cancer (cancer that has spread beyond its original site), the disease typically cannot be cured with currently available treatments.[19] In these situations, treatment shifts toward managing symptoms, slowing progression, and maintaining quality of life for as long as possible.

The stage and grade of the tumor are the most important factors affecting prognosis. Stage refers to how far the cancer has spread, while grade describes how abnormal the cancer cells look under a microscope. Low-grade tumors tend to grow slowly and have a better outlook, while high-grade tumors are more aggressive and carry a poorer prognosis.[24]

⚠️ Important
One particularly concerning aspect of ureteric cancer is its relationship with bladder cancer. Between 22% and 47% of people diagnosed with ureteric cancer will develop bladder cancer at some point in the future. When the cancer involves both the renal pelvis and ureter at the same time, the likelihood of subsequent bladder cancer increases to 75%.[2] This means that even after successful treatment, ongoing monitoring remains essential.

Natural Progression Without Treatment

If left untreated, ureteric cancer typically follows a predictable but concerning path of growth and spread. Understanding this natural progression helps illustrate why early detection and treatment are so crucial.

Cancer of the ureter begins in the cells lining the inside of the ureter, called transitional cells or urothelial cells. These special cells are designed to stretch when the ureter fills with urine and shrink when it empties.[8] When cancer develops, these cells begin to grow and divide in an uncontrolled manner.

In the earliest stages, the cancer remains on the surface of the ureter’s inner lining. At this point, it is considered superficial. Without intervention, however, the cancer cells continue to multiply and begin invading deeper layers of the ureter wall. The ureter wall consists of several layers: the inner lining, a thin layer of connective tissue called the lamina propria, and an outer thick muscle layer called the muscularis propria.[4]

As the disease advances, cancer cells penetrate through these layers one by one. Once the tumor reaches the muscle layer, it is considered muscle-invasive, which significantly worsens the prognosis. Eventually, if still untreated, the cancer breaks through the entire ureter wall and begins spreading to nearby tissues and organs.

The cancer may spread downward toward the bladder, or upward toward the kidney. It can also invade nearby structures such as blood vessels, lymph nodes, or surrounding fat tissue. In women, the cancer may spread to the vagina or bladder; in men, it may affect the prostate or areas around the penis.[9]

Beyond local spread, ureteric cancer can metastasize to distant organs through the bloodstream or lymphatic system. Common sites of distant spread include the lungs, liver, bones, and other organs. Once cancer reaches this advanced stage, it becomes much more difficult to control and significantly shortens life expectancy.

Possible Complications

Ureteric cancer and its treatment can lead to various complications that affect both immediate health and long-term wellbeing. Being aware of these potential issues helps patients and caregivers recognize warning signs early and seek appropriate medical attention.

One serious complication is obstruction of the ureter. As the tumor grows, it can block the flow of urine from the kidney to the bladder. This backup of urine can cause the kidney to swell, a condition called hydronephrosis. If left unaddressed, this can lead to kidney damage or kidney failure, especially if both ureters are affected.[17]

Blood in the urine, or hematuria, is a common symptom of ureteric cancer, but it can also become a complication. Heavy or persistent bleeding may lead to anemia, causing fatigue, weakness, and shortness of breath. In rare cases, blood clots may form in the urine, potentially blocking the urinary tract and causing severe pain.[3]

Infections represent another risk. When urine flow is obstructed or altered by cancer, bacteria can multiply more easily, leading to urinary tract infections or even more serious kidney infections. These infections may cause fever, chills, and worsening pain.[2]

As mentioned earlier, one of the most significant complications is the development of new cancers elsewhere in the urinary tract. People who have had ureteric cancer face an increased risk of developing bladder cancer, with studies showing that 30% to 50% of patients will develop bladder cancer after treatment for upper urinary tract cancer.[1] This risk is even higher when the cancer involves multiple areas of the urinary tract simultaneously.

Surgery to remove the ureter and kidney can lead to its own set of complications. Patients may experience narrowing of the ureter (stricture), blocked ureters, bleeding, infection, or an urgent need to urinate frequently.[12] If the entire kidney is removed, the remaining kidney must work harder to filter waste, which can be challenging, especially for older patients or those with pre-existing kidney problems.

Treatment with chemotherapy can cause side effects such as nausea, fatigue, loss of appetite, hair loss, and increased risk of infection due to lowered white blood cell counts. Radiation therapy may irritate the bladder and bowel, causing pain, frequent urination, or diarrhea.

Impact on Daily Life

Living with ureteric cancer affects nearly every aspect of daily life, from physical capabilities to emotional wellbeing, social relationships, and work responsibilities. Understanding these impacts can help patients and families adjust their expectations and find effective ways to cope.

Physically, the disease and its treatment often cause persistent fatigue, which can be overwhelming. This exhaustion is not the same as normal tiredness; it doesn’t improve with rest and can make even simple tasks feel insurmountable. Patients may struggle to maintain their usual routines, such as cooking, cleaning, or running errands.[3]

Pain is another common issue. Depending on where the cancer is located and whether it has spread, patients may experience back pain, flank pain (pain in the side of the body between the ribs and hip), or abdominal discomfort. This pain can interfere with sleep, making fatigue even worse and affecting concentration and mood during the day.[2]

Urinary symptoms significantly disrupt daily activities. Frequent urination, urgent needs to rush to the bathroom, burning sensations when urinating, and blood in the urine are distressing and embarrassing. These symptoms may make it difficult to travel, attend social events, or work outside the home. Some patients become anxious about being too far from a bathroom, which limits their willingness to leave home.[23]

For those who undergo surgery to remove the kidney and ureter, additional challenges arise. Some patients may need to manage a urostomy, an opening in the abdomen where urine drains into an external bag. Learning to care for a urostomy takes time and adjustment. Many people initially feel self-conscious about the bag and worry about leaks or odors, which can affect their confidence in social situations.[26]

Emotionally, the impact of a cancer diagnosis can be profound. Fear, anxiety, anger, sadness, and feelings of isolation are common. Many patients worry constantly about whether the cancer will come back or spread. This fear of recurrence can be especially intense before follow-up appointments and scans, creating a cycle of anxiety that affects mental health.[23]

Changes in body image and self-esteem are also significant. Surgical scars, weight loss or gain, hair loss from chemotherapy, or the presence of a urostomy bag can make patients feel less attractive or “different” from how they were before cancer. These feelings can strain intimate relationships and reduce interest in sexual activity.[26]

Work life may be disrupted by frequent medical appointments, fatigue, and side effects of treatment. Some patients need to reduce their hours, take extended leave, or even stop working entirely. This can lead to financial stress, especially when medical bills accumulate alongside lost income.

Social relationships may change as well. Some friends and family members may not know how to respond to the diagnosis and may withdraw, leaving the patient feeling isolated. Others may be overly concerned or treat the patient differently, which can be frustrating. Finding a balance between accepting help and maintaining independence is often challenging.[23]

Despite these challenges, many patients find ways to adapt and maintain a good quality of life. Setting small, achievable goals each day can provide a sense of accomplishment and control. Engaging in gentle physical activity, such as walking or stretching, can help reduce fatigue and improve mood. Talking openly with loved ones about needs and feelings strengthens relationships and reduces feelings of isolation.

Joining support groups, either in person or online, allows patients to connect with others who truly understand what they’re going through. Sharing experiences, tips, and encouragement with others facing similar challenges can be incredibly comforting and empowering.[23]

Support for Family Members

When someone is diagnosed with ureteric cancer, it affects not just the patient but the entire family. Family members often play a crucial role in supporting their loved one through diagnosis, treatment, and recovery, yet they may feel uncertain about how best to help, especially when it comes to clinical trials.

Clinical trials are research studies that test new treatments or new ways of using existing treatments. For patients with ureteric cancer, especially those with advanced disease, clinical trials may offer access to promising therapies not yet available through standard care. However, understanding clinical trials and helping a loved one decide whether to participate can be confusing.[7]

Family members can start by learning what clinical trials are and how they work. Clinical trials have strict eligibility criteria, and not every patient will qualify for every study. Trials may test new drugs, new combinations of existing drugs, new surgical techniques, or new radiation approaches. Some trials compare a new treatment to the current standard treatment to see which works better.

Relatives can assist their loved one in finding appropriate clinical trials by searching databases such as those provided by government health agencies or cancer research institutions. It helps to have a clear understanding of the patient’s specific diagnosis, including the stage and grade of the cancer, as well as what treatments have already been tried.

When considering a clinical trial, family members can help by attending medical appointments with the patient. Having a second person present ensures that important information is not missed and provides emotional support during discussions with doctors. Relatives can take notes, ask questions, and help the patient remember what was said later.

⚠️ Important
Before enrolling in a clinical trial, patients and families should understand the potential benefits and risks. Trials may offer access to cutting-edge treatments, but they may also involve additional tests, more frequent visits to the medical center, and uncertainty about whether the new treatment will be more effective than standard care. Family members should help ensure the patient feels fully informed and comfortable with the decision.

Practical support is equally important. Family members can help with transportation to appointments, especially if the clinical trial is being conducted at a hospital far from home. They can assist with managing medications, tracking side effects, and communicating with the medical team about any concerns that arise.

Emotional support cannot be underestimated. Participating in a clinical trial can bring both hope and anxiety. Family members should listen without judgment, validate the patient’s feelings, and offer reassurance. Sometimes, just being present and showing that you care makes all the difference.

It is also important for family members to take care of themselves. Supporting someone with cancer can be physically and emotionally exhausting. Caregivers should not hesitate to ask for help from other relatives, friends, or professional services. Taking breaks, maintaining their own health, and seeking counseling or support groups for caregivers can help prevent burnout.

Understanding the patient’s wishes regarding treatment decisions, including participation in clinical trials, is essential. Open, honest conversations about hopes, fears, and goals help ensure that the patient’s values guide their care. Family members should respect the patient’s autonomy while offering guidance and support.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Mitomycin C – A chemotherapy drug that can be administered topically into the ureter to treat cancer cells locally
  • Mitomycin pyelocalyceal (Jelmyto) – An FDA-approved formulation of mitomycin specifically designed for instillation into the upper urinary tract to treat low-grade ureteral cancer
  • Bacillus Calmette-Guérin (BCG) – A biologic therapy that can be instilled into the urinary tract to stimulate an immune response against cancer cells
  • Nivolumab – An immunotherapy drug approved for certain patients following surgery who are not eligible for chemotherapy

Ongoing Clinical Trials on Ureteric cancer

References

https://www.mayoclinic.org/diseases-conditions/ureteral-cancer/symptoms-causes/syc-20360721

https://www.saintjohnscancer.org/urology/conditions/ureteral-cancer/

https://www.cedars-sinai.org/health-library/diseases-and-conditions/u/ureter-cancer.html

https://cancer.ca/en/cancer-information/cancer-types/renal-pelvis-and-ureter/what-is-cancer-of-the-renal-pelvis-or-ureter

https://www.mayoclinic.org/diseases-conditions/ureteral-cancer/diagnosis-treatment/drc-20360722

https://www.loyolamedicine.org/services/cancer/cancer-conditions/ureter-cancer

https://blog.dana-farber.org/insight/2021/12/what-is-ureteral-cancer/

https://www.cancer.gov/types/kidney/patient/transitional-cell-treatment-pdq

https://uciurology.com/urological-cancers/ureter-cancer/

https://www.mayoclinic.org/diseases-conditions/ureteral-cancer/diagnosis-treatment/drc-20360722

https://www.cancer.gov/types/kidney/patient/transitional-cell-treatment-pdq

https://cancer.ca/en/cancer-information/cancer-types/renal-pelvis-and-ureter/treatment

https://www.saintjohnscancer.org/urology/conditions/ureteral-cancer/

https://www.froedtert.com/prostate-cancer/bladder-ureteral-cancer/ureter-cancer

https://uciurology.com/urological-cancers/ureter-cancer/

https://emedicine.medscape.com/article/452449-treatment

https://www.cedars-sinai.org/health-library/diseases-and-conditions/u/ureter-cancer.html

https://www.foxchase.org/clinical-care/conditions/ureteral-cancer/treatment

https://www.ncbi.nlm.nih.gov/books/NBK66010/

https://www.cxbladder.com/us/blog/managing-life-after-bladder-cancer/

https://www.cancer.org/cancer/types/bladder-cancer/after-treatment/follow-up.html

https://www.mayoclinic.org/diseases-conditions/ureteral-cancer/diagnosis-treatment/drc-20360722

https://www.cancerresearchuk.org/about-cancer/bladder-cancer/living-with/coping

https://cancer.ca/en/cancer-information/cancer-types/renal-pelvis-and-ureter/prognosis-and-survival

https://www.cxbladder.com/us/blog/newly-diagnosed-with-bladder-cancer/

https://www.cancer.gov/types/bladder/coping

https://www.drrajeshdhakeurologist.com/living-with-urinary-cancer-coping-mechanisms-and-support/

FAQ

Can ureteric cancer be cured?

Yes, ureteric cancer can be cured if detected early when it is still superficial and confined to the ureter lining. More than 90% of patients with superficial cancers can be cured with appropriate treatment. However, deeply invasive or metastatic cancers have much lower cure rates.[19]

What are the main warning signs of ureteric cancer?

The most common warning signs include blood in the urine (which may be visible or detected only through testing), persistent back or flank pain that doesn’t go away, unexplained weight loss, painful or frequent urination, and extreme fatigue.[7]

Why do people with ureteric cancer need ongoing monitoring even after successful treatment?

Ureteric cancer has a high risk of recurrence and is strongly associated with bladder cancer. Between 30% and 50% of patients treated for ureteric cancer will develop bladder cancer in the future, which is why regular follow-up exams and tests are essential.[1]

Will I lose my kidney if I have ureteric cancer?

Not always. The most common surgical treatment is radical nephroureterectomy, which removes the entire kidney, ureter, and a portion of the bladder. However, in select cases with small, low-grade tumors, kidney-sparing procedures such as segmental resection or endoscopic surgery may be possible.[12]

Is ureteric cancer related to smoking?

Yes, smoking is a significant risk factor for ureteric cancer. Smoking is believed to cause about half of all bladder cancers, and because ureteric cancer involves the same type of cells, smoking similarly increases the risk of developing cancer in the ureters.[3]

🎯 Key takeaways

  • Ureteric cancer is rare, accounting for only 4% of upper urinary tract tumors, but it requires aggressive treatment and lifelong monitoring
  • Early detection is critical—more than 90% of superficial cancers can be cured, but deeply invasive cancers have cure rates of only 10-15%
  • Up to 47% of patients with ureteric cancer will develop bladder cancer in the future, making ongoing surveillance essential
  • The same transitional cells that line the ureters also line the bladder, explaining why these cancers are closely related
  • Surgery is the primary treatment, and while many patients require removal of the kidney and ureter, kidney-sparing options may be possible in select cases
  • Living with ureteric cancer impacts physical health, emotional wellbeing, relationships, and work, but support systems and coping strategies can significantly improve quality of life
  • Family members play a crucial role in helping patients navigate treatment decisions, including participation in clinical trials
  • Lynch Syndrome, an inherited condition, is found in about 21% of patients with upper tract urothelial carcinoma, highlighting the importance of genetic evaluation